News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis and HIV
Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection

A simple blood test can predict the risk of liver-related death or hepatic encephalopathy for people living with HIV who have hepatitis B or hepatitis C

Published
17 June 2013
By
Michael Carter
New and experimental hepatitis C treatment
AbbVie Says It Can Be First With New Hepatitis C Drugs

AbbVie Inc. (ABBV) said it can win the race against Gilead Sciences Inc. (GILD) to bring to market a new generation of all-oral hepatitis C drugs.

Published
14 June 2013
From
Bloomberg
Hepatitis B
Hepatitis B Viral Levels May Soar When Vitamin D Drops

Insufficient serum levels of vitamin D, which ebb and flow with sun exposure, are associated with high levels of hepatitis B virus (HBV) replication in treatment-naive people who suffer from chronic infection.

Published
11 June 2013
From
Medscape (requires registration)
New and experimental hepatitis C treatment
FDA Grants Priority Review To Oral Hepatitis C Drug Sofosbuvir, Approval Set For December

Gilead's drug will be the first to hit the market in a new generation of targeted hepatitis C treatments with high cure rates.

Published
10 June 2013
From
Medical Daily
Hepatitis C symptoms and diagnosis
Blood tests OK for fibrosis diagnosis in hep C

Blood testing can accurately identify clinically significant fibrosis and cirrhosis in people with hepatitis C virus (HCV) infection and may be an alternative to liver biopsy in some patients, a new systematic review has found.

Published
05 June 2013
From
MedPage Today
New and experimental hepatitis C treatment
Drugs Go From Hit to Dud in Two Years in Hepatitis Race

The pace of innovation, spurred by drugmakers jostling for a slice of a market that may reach $15 billion by 2018, has turned hepatitis C research into one of the fastest-developing areas of medicine. That boosted Gilead’s shares to a record last month, and left others like Vertex facing dwindling sales as their products quickly go from revolutionary to outdated.

Published
04 June 2013
From
Bloomberg
Hepatitis C treatment
INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)

Janssen Infectious Diseases-Diagnostics announced today that the European Commission has approved a new twice-daily dosing of INCIVO® (telaprevir), a direct-acting antiviral hepatitis C protease inhibitor, in combination with pegylated-interferon and ribavirin (PR) for naive and previous-treatment experienced patients.

Published
31 May 2013
From
PR Newswire
New and experimental hepatitis C treatment
An all-oral combination phase II study of Simeprevir and Samatasvir (IDX719) for the treatment of hepatitis C virus infection initiated

Medivir today announced that Idenix Pharmaceuticals Inc. has initiated a phase II clinical trial, called HELIX-1, evaluating an all-oral, direct-acting antiviral (DAA) HCV combination regimen of simeprevir, a once-daily protease inhibitor jointly developed by Medivir and Janssen R&D Ireland, and samatasvir (IDX719), Idenix’s once-daily pan-genotypic NS5A inhibitor.

Published
30 May 2013
From
Medivir
Injecting drug users
'War on drugs' fuelling the hepatitis C epidemic among people who inject drugs

The global war on drugs has had a disastrous impact on the hepatitis C epidemic, a new report from the Global Commission on Drug Policy shows. The Negative

Published
29 May 2013
By
Michael Carter
Hepatitis C treatment
Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010

France led the world in the proportion of its hepatitis C patients who received treatment in 2010, but some countries in southern and eastern Europe had treatment

Published
28 May 2013
By
Keith Alcorn
← First12345...104Next →

Filter by country